Hannah Joseph Hospital IPO opens for subscription on January 22, 2026, and closes on January 27, 2026, with an issue size of ₹42 crore entirely as a fresh issue listed on BSE SME. The Kochi-based multi-specialty hospital offers cardiology, neurology, orthopedics, maternity, and emergency services across 150+ beds, featuring NABH-accredited facilities and advanced diagnostics. Hannah Joseph Hospital IPO provides exposure to India’s healthcare capacity growth amid rising demand for specialized treatments and insurance coverage.
₹00
₹70
₹
Expert Opinions
Market sentiment for Hannah Joseph Hospital IPO reflects measured optimism among SME healthcare investors, drawn to Kerala’s medical tourism strengths despite broader market caution. Company strengths include NABH accreditation, specialized cardiology and neurology expertise, 150+ bed capacity utilization above 70%, and strategic Kochi location serving Gulf repatriates. Risks involve doctor retention challenges, regulatory compliance for expansion, reimbursement delays from insurance providers, and competition from larger hospital chains.
Valuation analysis for Hannah Joseph Hospital IPO and year 2025 indicates Return on Equity (ROE) of 14.77%, ROCE of 17.03%, and Net Asset Value (NAV) of ₹29.30, trading at reasonable multiples for steady occupancy growth. Long-term investment perspective favors portfolios seeking defensive healthcare exposure, with potential from oncology unit additions and insurance penetration rising to 50% by 2030.
Investor Considerations
Hannah Joseph Hospital IPO investors should assess the company’s robust fundamentals, with revenue expanding from ₹54.62 crore in FY23 to ₹77.53 crore in FY25 at 19.35% CAGR and PAT surging 613.86% to ₹7.21 crore, reflecting improved bed occupancy above 70%. Healthcare sector outlook accelerates with hospital bed demand doubling by 2030, boosted by medical tourism and insurance penetration reaching 50%.
Valuation analysis for Hannah Joseph Hospital IPO in 2025 reveals Price to Book Value of 2.66, PAT Margin of 9.30%, and Debt/Equity ratio of 0.65, balancing growth with conservative financing. Growth prospects feature radiation oncology expansion and 300-bed capacity addition targeting Kerala’s Gulf patient inflows. Risk factors include specialist doctor retention, reimbursement delays, and regional competition intensity. Long-term horizons capture compounding healthcare demand, unlike short-term SME listing fluctuations.
| Date | GMP | Trend |
|---|---|---|
| 01 Feb 2026 13.43 | ₹00 | --- |
| 30 Jan 2026 19.27 | ₹00 | --- |
| 29 Jan 2026 20.04 | ₹00 | --- |
| 28 Jan 2026 20.36 | ₹00 | --- |
| 27 Jan 2026 21.32 | ₹00 | --- |
| 26 Jan 2026 18.35 | ₹00 | --- |
| 22 Jan 2026 21.15 | ₹00 | --- |
| 21 Jan 2026 20.30 | ₹00 | --- |
| 19 Jan 2026 20.10 | ₹00 | --- |
FAQs
Hannah Joseph Hospital IPO Current GMP is ₹00.
Hannah Joseph Hospital IPO Expected Returns is 0.00%.
Hannah Joseph Hospital IPO estimated listing price is ₹70.